Many companies have tried and failed to make an HIV vaccine capable of preventing HIV infection, but the virus has eluded more than 30 vaccines so far. Read More
The Good Pharma Scorecard (GPS) released last week by the not-for-profit Bioethics International contained surprisingly good news. Two companies – Johnson & Johnson (J&J) and Sanofi SA – of 11 ranked on overall clinical trial transparency, based on drugs approved in 2014, achieved scores of 100 percent, tying them at the top of the list. Four others – Abbvie Inc., Celgene Corp., Merck & Co. Inc. and Astrazeneca plc – scored at or above the industry median of 91 percent. Read More